Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by georges44on Jan 05, 2008 4:34pm
151 Views
Post# 14156734

Short

Short

Short History
Symbol Report Date Volume Change
  PLI - T 2007-12-31 -15,733
  PLI - T 2007-12-15 15,733 -169,267
  PLI - T 2007-11-30 185,000 62,000
  PLI - T 2007-11-15 123,000 -27,000
  PLI - T 2007-10-31 150,000 -1,252,800
  PLI - T 2007-10-15 1,402,800 866,300
  PLI - T 2007-09-30 536,500 536,500
  PLI - T 2007-09-15 -1,800
Bullboard Posts